Publications:

A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies.

Cancer Chemotherapy And Pharmacology

Lynce, Filipa F; Wang, Hongkun H; Petricoin, Emanuel F EF; Pohlmann, Paula R PR; Smaglo, Brandon B; Hwang, Jimmy J; He, Aiwu R AR; Subramaniam, Deepa S DS; Deeken, John J; Marshall, John J; Pishvaian, Michael J MJ

Publication Date: 2019-11

Variant appearance in text: HER2: y1248=

PubMed Link: 31538230

Variant Present in the following documents:

• Main text

View BVdb publication page

Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas.

Cell Reports

Way, Gregory P GP; Sanchez-Vega, Francisco F; La, Konnor K; Armenia, Joshua J; Chatila, Walid K WK; Luna, Augustin A; Sander, Chris C; Cherniack, Andrew D AD; Mina, Marco M; Ciriello, Giovanni G; Schultz, Nikolaus N; , ; Sanchez, Yolanda Y; Greene, Casey S CS

Publication Date: 2018-04-03

Variant appearance in text: ERBB2: 3744C>T

PubMed Link: 29617658

Variant Present in the following documents:

• NIHMS958974-supplement-5.xlsx, sheet 1
• NIHMS958974-supplement-6.xlsx, sheet 1

View BVdb publication page